
Dabigatran etexilate
CAS No. 211915-06-9
Dabigatran etexilate ( BIBR-1048 )
产品货号. M13373 CAS No. 211915-06-9
BIBR-953 的前药,是一种有效的非肽凝血酶抑制剂,Ki 为 4.5 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥267 | 有现货 |
![]() ![]() |
5MG | ¥421 | 有现货 |
![]() ![]() |
10MG | ¥583 | 有现货 |
![]() ![]() |
50MG | ¥721 | 有现货 |
![]() ![]() |
100MG | ¥972 | 有现货 |
![]() ![]() |
200MG | ¥1418 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Dabigatran etexilate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BIBR-953 的前药,是一种有效的非肽凝血酶抑制剂,Ki 为 4.5 nM。
-
产品描述A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM; 10-fold less potent for Trypsin and no activity against Factor Xa, Plasmin, tPA and activated protein C; exhibits strong and long-lasting anticoagulant effects ex vivo and strong oral activity in different animal species.Thrombosis Approved(In Vitro):Dabigatran etexilate (BIBR 1048; oral; 10, 20 and 50 mg/kg for rats and 1, 2.5 and 5 mg/kg for monkeys) has dose- and time-dependent anticoagulant effects and has maximum effects between 30 and 120 min after administration, respectively.Dabigatran etexilate maximally and significantly prolongs partial thromboplastin time (aPTT) to 25.2, 38.4 and 78.3 s in 30 min after 10, 20 and 50 mg/kg oral doses, respectively.Dabigatran etexilate maximally prolongs the aPTT to 34.3 s, 44.0 s, and 63.0 s, respectively, 2h after 1, 2.5 or 5 mg/kg doses in the monkey.
-
体外实验——
-
体内实验Dabigatran etexilate (BIBR 1048; oral; 10, 20 and 50 mg/kg for rats and 1, 2.5 and 5 mg/kg for monkeys) has dose- and time-dependent anticoagulant effects and has maximum effects between 30 and 120 min after administration, respectively. Dabigatran etexilate maximally and significantly prolongs partial thromboplastin time (aPTT) to 25.2, 38.4 and 78.3 s in 30 min after 10, 20 and 50 mg/kg oral doses, respectively.Dabigatran etexilate maximally prolongs the aPTT to 34.3 s, 44.0 s, and 63.0 s, respectively, 2h after 1, 2.5 or 5 mg/kg doses in the monkey. Animal Model:Male rats (280-350 g) and rhesus monkeys of either sex (3-8 kg)Dosage:10, 20 and 50 mg/kg for rats and 1, 2.5 and 5 mg/kg for monkeys Administration:Oral Result:Had dose- and time-dependent anticoagulant effects.
-
同义词BIBR-1048
-
通路Autophagy
-
靶点Thrombin
-
受体Thrombin
-
研究领域Cardiovascular Disease
-
适应症Thrombosis
化学信息
-
CAS Number211915-06-9
-
分子量627.7332
-
分子式C34H41N7O5
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(OCC)CCN(C1=NC=CC=C1)C(C2=CC=C3N(C)C(CNC4=CC=C(/C(N)=N\C(OCCCCCC)=O)C=C4)=NC3=C2)=O
-
化学全称b-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hauel NH, et al. J Med Chem. 2002 Apr 25;45(9):1757-66.
2. Wienen W, et al. Thromb Haemost. 2007 Jul;98(1):155-62.
3. Baetz BE, et al. Pharmacotherapy. 2008 Nov;28(11):1354-73.
产品手册




关联产品
-
Protamine sulfate
Protamine sulfate 是一个阳性离子肽,具有抗肝素活性,可以中和肝素的抗凝血作用,增强脂质介导的基因转移。
-
Dabigatran
一种可逆、选择性的直接凝血酶抑制剂 (DTI),Ki 值为 4.5 nM。
-
Melagatran
Melagatran 是具有口服活性的 thrombin 直接抑制剂,除凝血酶外,它与凝血级联反应中的任何其他酶或纤溶酶没有相互作用。Melagatran 的抗凝血酶作用不需要内源性辅因子,可能有助于减轻内毒素血症的某些破坏作用。 Melagatran 具有预防动脉阻塞的潜能。